Loading clinical trials...
Loading clinical trials...
Predicting Long-term Prognosis in Erdheim-Chester Disease: A New Comprehensive Approach
Conditions
Locations
7
United States
National Institute of Health
Bethesda, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Hopital Pitiè-Salpetriere
Paris, France
Meyer Children's Hospital IRCCS, Firenze
Florence, Fi, Italy
San Raffaele Hospital
Milan, Italy, Italy
Start Date
December 23, 2024
Primary Completion Date
June 1, 2028
Completion Date
December 1, 2028
Last Updated
March 6, 2026
Lead Sponsor
Meyer Children's Hospital IRCCS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions